In the long-term, discovery of new drugs against leptin resistance, acting at multiple levels, should be included in a therapeutic setting where combinatorial treatment in association with other hormonal therapies should help decreasing food intake and increasing energy expenditure and therefore leading to steady reversal of obesity with limited risks. The gene discussed is LEP; the disease is Obesity.